Skybiotech Healthcare share news and announcements
BSE: 512036Textiles & ApparelsSmall Cap
Last close ₹116.50down ₹0.50 (0.43%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹117.00.
52-week range of traded prices to 23 Oct 2026
₹113.90Low, 28 Sep 2026₹218.20High, 2 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹22 Cr3,866th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 2.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.91
- Volume, BSEVolume. Shares traded on the last trading day.
- 25
Skybiotech Healthcare results
95 filed, newest first. Page 2 of 2.
Oct 2018
13 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2018
May 2018
Feb 2018
Dec 2017
Nov 2017
Sep 2017
Aug 2017
May 2017
Feb 2017
Nov 2016
Oct 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
Aug 2015
Jun 2015
Feb 2015
Nov 2014
Aug 2014
May 2014
Feb 2014
Nov 2013
Aug 2013
May 2013
Apr 2013
27 Apr · Results
Company intends to publish Audited Result for the Financial Year 2012-13 within a period of Sixty days from the end of the last Quarter of Financial ....
Feb 2013
Nov 2012
Aug 2012
Jun 2012
May 2012
7 May · Results
Company intends to publish Audited Result for the financial year 2011-2012. Within a period of sixty days from the end of the Last quarter of financial ....
Feb 2012
Nov 2011
May 2011
2 May · Results
Company intends to publish Audited Result for the financial year 2010-2011 .Within a period of sixty days from the end of the Last quarter of financial ....
Feb 2011
Nov 2010
Aug 2010
Jun 2010
Apr 2010
21 Apr · Results
Company intends to publish Audited Result for financial year 2009-2010. Within a period of sixty days from the end of the last quarter of financial year. ....